President and Chief Executive Officer
Mars Innovation, Canada
Dr. Hofstein received his PhD and Master of Science degrees in Life Sciences and Chemistry from the Weizmann Institute of Science in Rehovot, Israel. His Bachelor of Science degree in Chemistry and Physics was attained from the Hebrew University in Jerusalem. Awards received while completing post-doctoral training and research at the Harvard Medical School in Boston in the Departments of Biological Chemistry and Neurobiology include the Hereditary Disease Foundation Fellowship in 1982-83, and the Chaim Weizmann Postdoctoral Fellowship in 1980-82.
From 1999 to June 2009 Dr. Hofstein held the position of President and CEO of Hadasit Ltd., the technology transfer company of the Hadassah Medical Organization in Jerusalem. He serves as Chair of Hadasit BioHolding Ltd., a holding company for a cluster of companies engaged in drug development and medical diagnostics. Hadasit BioHolding Ltd. has been publicly traded on the Tel Aviv Stock Exchange (TASE) since 2006. Dr. Raphael (Rafi) Hofstein joined MaRS Innovation as President and CEO in June 2009.
